InvestorsHub Logo
Followers 86
Posts 7410
Boards Moderated 0
Alias Born 02/03/2018

Re: Nukemtiltheyglow post# 354716

Thursday, 09/16/2021 10:41:10 PM

Thursday, September 16, 2021 10:41:10 PM

Post# of 428722
Nuke, as Zip mentioned, Vascepa/Statin combo would be the best proposition. Pfizer is fully aware of Amarin's combo patent. Any physician knows better compliance is sustained with fewer pills to swallow. You'd be surprised at the drop out rate, particularly in older people when they have multiple pills to swallow.

As they say, if you have a great idea, chances are someone has already thought of it. Pfizer must have a plan, and it's not just Canada. That's peanuts for them.

ILT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News